Drug Delivery

New licensed-in technology turns injectable drugs into oral formulations

Published in Blood Weekly, November 28th, 2002

Debiopharm S.A. announced the licensing-in of an innovative technology, based on the formulation of microparticles prepared with blends of biodegradable and polycationic polymers, to examine the feasibility of developing oral delivery of macromolecules.

The technology was licensed from three researchers based at the University Henri Poincar in Nancy, France. Profs. P. Maincent, C. Vigneron, and Dr. N. Ubrich, the researchers, have filed a patent application on the particular carriers developed to improve the oral absorption of large biomolecules such as low molecular weight heparin, peptides, and proteins. The research will be performed at the Department of Pharmacy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-11-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry